C
NRIX icon

Covestor’s Nurix Therapeutics NRIX Stock Holding History

Covestor’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
9
– – ﹤0.01% 2613
2025
Q4 		$0 Hold
9
– – ﹤0.01% 2588
2025
Q3 		$0 Hold
9
– – ﹤0.01% 2601
2025
Q2 		$0 Buy
9
+4
+80% +$43 ﹤0.01% 2573
2025
Q1 		$0 Hold
5
– – ﹤0.01% 2566
2024
Q4 		$0 Hold
5
– – ﹤0.01% 2574
2024
Q3 		$0 Sell
5
-2
-29% -$45 ﹤0.01% 2571
2024
Q2 		$0 Buy
+7
New +$109 ﹤0.01% 2584
2022
Q2 		– Sell
-13
Closed – – 2205
2022
Q1 		$0 Buy
13
+2
+18% +$36 ﹤0.01% 2320
2021
Q4 		$0 Buy
+11
New +$333 ﹤0.01% 2231

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Covestor's NRIX Position: Q1 2026 in Review

Covestor held its Nurix Therapeutics (NRIX) position steady in Q1 2026 at 9 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2613.

Covestor first reported a position in NRIX in Q4 2021 and has held it in 10 quarters since. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • Covestor held 9 shares of Nurix Therapeutics worth $0 as of Q1 2026.
  • Covestor left its Nurix Therapeutics share count unchanged in Q1 2026.
  • Nurix Therapeutics made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2613 holding.
  • Covestor first reported a position in Nurix Therapeutics in Q4 2021 and has held it in 10 quarters since.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.